Last reviewed · How we verify
NCT03776383: OPTIMISE
Providing Antibiotic Prescribing Feedback to Primary Care Physicians: The Ontario Program To Improve AntiMicrobial USE
NA trial testing Antibiotic use feedback letter in Antibiotic Prescribing Audit and Feedback in 3,500 participants. Completed in 30 November 2020.
30 November 2019
Quick facts
| Lead sponsor | Ontario Agency for Health Protection and Promotion |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 3,500 |
| Start date | 14 December 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 November 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Antibiotic use feedback letter
Conditions studied
- Antibiotic Prescribing Audit and Feedback — all drugs for Antibiotic Prescribing Audit and Feedback →
Sponsor
Ontario Agency for Health Protection and Promotion
Who can join
Eligibility, any sex, with Antibiotic Prescribing Audit and Feedback. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Antibiotic overuse occurs in multiple jurisdictions and is associated with rising rates of antimicrobial resistance. Mailing letters to the highest antibiotic prescribing physicians is a potentially effective method to optimize antibiotic use. The objectives of this study are to improve enrollment to Health Quality Ontario's Primary Care Practice report and reduce unnecessary antibiotic use. The investigators are conducting a randomized controlled trial recruiting the 3500 highest antibiotic prescribing primary care physicians in Ontario. The investigators have incorporated behavioural science theory into designing letters to modify prescribing behaviour. Letter 1 is testing change ideas related to antibiotic initiation and letter 2 is testing change ideas related to antibiotic duration. There will be 1500 physicians receiving letter 1, 1500 receiving letter 2, and 500 will serve as controls. Twelve months later all 3500 physicians will receive a letter.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of Antibiotic-Prescribing Feedback to High-Volume Primary Care Physicians on Number of Antibiotic Prescriptions: A Randomized Clinical Trial.
Schwartz KL, Ivers N, Langford BJ, Taljaard M, et al · · 2021 · cited 44× · PMID 34228086 · DOI 10.1001/jamainternmed.2021.2790 -
Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older.
Schwartz KL, Chen C, Langford BJ, Brown KA, et al · · 2019 · cited 20× · PMID 31557249 · DOI 10.1371/journal.pone.0223097 -
2020 Annual Conference Conférence Annuelle.
· 2021 · PMID 36339318 · DOI 10.3138/jammi.6.s1.abst -
Oral Presentations
Xia Y, Tunis M, Frenette C, Katz K, et al ·
Verify or expand the search:
- PubMed search for NCT03776383
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03776383 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ontario Agency for Health Protection and Promotion
- Last refreshed: 3 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03776383.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing